Literature DB >> 8976108

[Hyperuricemia and insulin resistance].

T Wasada1, K Katsumori, A Saeki, M Iwatani.   

Abstract

Hyperuricemia is often associated with obesity, hypertension and dyslipidemia, and is thought to be a risk factor for cardiovascular disease, thereby making resemblance to the insulin resistance syndrome. Our data showed a low, but significant correlation between serum uric acid concentration and the degree of insulin resistance (GIR) estimated by euglycemic hyperinsulinemic clamp method in 67 subjects with combined normal glucose tolerance and IGT(r = -0.278, p < 0.05). Plasma HDL-C and TG levels were also correlated with uric acid levels. One hundred sixty NIDDM patients who had undergone the clamp study were stratified into 5 groups according to the serum uric acid level. In the top quintile (UA : 7.8 +/- 0.8 mg/dl), BMI, male prevalence, plasma TG, HDL-C, fasting IRI, and total IRI response(0 + 60 + 120 min) during meal tolerance test were significantly higher, while age and GIR value tended to be lower without significance compared with those in the bottom quintile (UA : 3.4 +/- 0.5 mg/dl). These results, which are in agreement with the previous studies, support the notion that elevated serum uric acid is a feature of insulin resistance syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976108

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  2 in total

1.  Rationale and design for Lowering-hyperUricaemia treatment on cardiovascular outcoMes In peritoNeal diAlysis patients: a prospective, multicentre, double-blind, randomised controlled trial (LUMINA).

Authors:  Wei Chen; Naya Huang; Haiping Mao; Xiao Yang; Qian Zhou; Lanping Jiang; Jun Ding; Qiong Feng; Xueqing Yu
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

2.  Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients?

Authors:  Emre Tutal; Burak Sayın; Derun Taner Ertugrul; Avsin Ibis; Siren Sezer; Nurhan Ozdemir
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.